This off-target binding is the likely contributor to its cortisol and ACTH co-secretion, as it stimulates the hypothalamic-pituitary-adrenal axis in addition to the GH axis
Appendix Search String Employed for the Systematic Review (INDEXTERMS (GLP-1 analog OR glucagon-like peptide-1 analog OR GLP-1 receptor agonist OR glucagon-like peptide-1 receptor agonist OR glp-1 receptor agonists OR glp1 receptor agonist OR glucagon-like OR exenatide OR lixisenatide OR eperzan OR tanzeum OR albiglutide OR dulaglutide OR liraglutide OR semaglutide OR taspoglutide OR tanzeum OR trulicity OR byetta OR bydureon OR victoza OR adlyxin OR ozemoic OR saxenda OR bydureon OR ITCA 650 OR Exendin-4 OR Exendin 4 OR byetta OR adlyxin OR lyxumia OR rGLP-1 protein OR ozempic) OR TITLE-ABS-KEY (GLP-1 analog OR glucagon-like peptide-1 analog OR GLP-1 receptor agonist OR glucagon-like peptide-1 receptor agonist OR glp-1 receptor agonists OR glp1 receptor agonist OR glucagon-like OR exenatide OR lixisenatide OR eperzan OR tanzeum OR albiglutide OR dulaglutide OR liraglutide OR semaglutide OR taspoglutide OR tanzeum OR trulicity OR byetta OR bydureon OR victoza OR adlyxin OR ozemoic OR saxenda OR bydureon OR ITCA 650 OR Exendin-4 OR Exendin 4 OR byetta OR adlyxin OR lyxumia OR rGLP-1 protein OR ozempic)) AND (INDEXTERMS (NASH OR Liver OR Fatty Liver OR steatohepatitis OR Steatosis of Liver OR Visceral Steatosis OR steatosis OR Liver Steatosis OR Non-alcoholic Fatty Liver Disease OR Non alcoholic Fatty Liver Disease OR NAFLD OR Nonalcoholic Fatty Liver Disease OR nonalcoholic OR Non alcoholic OR Nonalcoholic Fatty OR Non-alcoholic Fatty OR Nonalcoholic Fatty Liver OR Nonalcoholic Fatty Livers OR Nonalcoholic Steatohepatitis OR steatohepatitis OR steatotic) OR TITLE-ABS-KEY (NASH OR Liver OR Fatty Liver OR steatohepatitis OR Steatosis of Liver OR Visceral Steatosis OR steatosis OR Liver Steatosis OR Non-alcoholic Fatty Liver Disease OR Non alcoholic Fatty Liver Disease OR NAFLD OR Nonalcoholic Fatty Liver Disease OR nonalcoholic OR Non alcoholic OR Nonalcoholic Fatty OR Non-alcoholic Fatty OR Nonalcoholic Fatty Liver OR Nonalcoholic Fatty Livers OR Nonalcoholic Steatohepatitis OR steatohepatitis OR steatotic)) AND (INDEXTERMS (randomized clinical trial OR Randomized controlled trial OR random allocation OR randomized OR clinical trial OR random OR trial OR blind OR controlled trial OR controlled study OR randomized trial OR clinical study) OR TITLE-ABS-KEY (randomized clinical trial OR Randomized controlled trial OR random allocation OR randomized OR clinical trial OR random OR trial OR blind OR controlled trial OR controlled study OR randomized trial OR clinical study))
They are highly toxic to the liver and are amongst the major identified risk factors for hepatocellular carcinoma 10,11,12
Gastrointestinal symptoms that some patients experience during treatment (such as nausea, vomiting, or altered bowel habits) typically improve within two to three weeks of discontinuation, though the extended half-life means these effects may persist longer than with shorter-acting medications
They can also offer guidance on maintaining optimal B12 levels through diet and lifestyle modifications
Specifically, the Z Vent Ventilator "was evaluated to test for MRI compatibility only by using the 3T MRI scanner" with "no rationale or justification for lack of testing with the 1.5T MRI scanner." The labeling specified placement behind the 130 Gauss field line for 3T MRI magnets but"fails to specify how far the ventilator should be placed when using 1.5T MRI
